Innovaderm's Company Updates and News

Innovaderm will be at the EADV Congress in Berlin!

We are excited to be attending the EADV congress in Berlin from October 11th - 14th 2023! For the occasion, our European and North American teams will be reunited in Berlin and ready to meet with you at booth J33. Contact us now to book your meeting with our team of experts!   Innovaderm's full […]

End-to-end Expertise: Handling the Entire Journey from Conception to Approval

Following the recent FDA approval of Dermavant’s VTAMA® (tapinarof) cream 1% for the treatment of plaque psoriasis in adults, we are proud to share more about its development process and the successful collaboration between Innovaderm and Dermavant. Tapinarof was discovered by Canadian scientists and its development was initiated by Welichem, a Canadian company. Tapinarof is […]

Innovaderm’s leading expertise and experience in advancing the science of dermatology is to be featured at the World Congress of Dermatology (WCD) late breaking session

Innovaderm’s expertise will be featured at the World Congress of Dermatology’s (WCD) late-breaking session on July 4, 2023. Dr. Robert Bissonnette will be presenting the results of a recent phase II trial for a potential new treatment for Moderate-to-Severe Plaque Psoriasis (FRONTIER1).  Some authors of the abstract include Robert Bissonnette from Innovaderm, Megan Miller, Yaung-Kaung […]

Welcome to Cedric Burg, our new Chief Operating Officer!

Innovaderm appoints Cedric Burg as new Chief Operating Officer    [MONTREAL, QUEBEC – June 15, 2023]  Innovaderm welcomes Cedric Burg as its new Chief Operating Officer. Mr. Burg’s new role entails the management of Innovaderm’s global operations in Canada, through the close collaboration between department heads while overseeing most of Innovaderm’s activities.  Cedric has a combined […]

Anne Marie Gaulin, Recently Nominated as Executive VP European Expansion

We are more than happy to announce that our very own Anne Marie Gaulin, a long time Innovaderm executive, is taking on a new role as the new Executive VP - Europe Expansion! To learn more: Contact us Newsletter Get notified to have the latest trends and be at the forefront of dermatology clinical […]

Innovaderm recognized by pharma and biotech sponsors as top performer champion, sweeping all categories of the 2023 CRO Leadership Awards 

Innovaderm is the only organization winning the CHAMPION title in all 5 categories of the CRO Leadership Awards🏆🙌🏽 "I just thought: Wow, this is pretty impressive!" Penelope Przekop, CEO @PDC Pharma Strategy Listen to Jason Shuris, CBO @Innovaderm Research, sharing about Innovaderm's successes while being interviewed by Penelope Przekop during the 2023 CRO Leadership Awards […]

Innovaderm’s leading expertise and experience in advancing the science of dermatology is to be featured at the American Academy of Dermatology (AAD) late breaking session

Innovaderm’s leading expertise and experience in advancing the science of dermatology is to be featured at the American Academy of Dermatology (AAD) late breaking session on March 18, 2023. Dr. Robert Bissonnette will be presenting the results of a recent phase III trial for a potential new treatment for moderate-to-severe CHE.  The authors of the […]

Giving Back to the Community

Innovaderm has donated $300,000 to The Montreal Dermatology Research Institute (MDRI). This is our second consecutive contribution to the charity to fund critical research into skin disease. The MDRI was established in 2017 to promote education and conduct research on the prevention, screening, diagnosis and treatment of dermatological conditions. Innovaderm is proud of its shared […]

Webinar: Tips for a Successful Study in Medical Aesthetics

Join us on December 8th at 11:00 am EDT for an exciting webinar on how to mitigate factors and variability that can arise in a medical aesthetics study with panelists: Dr. Jasmina Jankicevic (Chief Medical Officer, Innovaderm Research) Nalanie Johnson (Project Manager, Innovaderm Research) Nicolas Dapis (Chief Business Officer - Clinical Services, QuantifiCare) Come learn […]

Introducing Jasmina Jankicevic, MD, MSc, CCRP, our new Chief Medical Officer!

Innovaderm extends a warm welcome to Dr. Jankicevic, a key opinion leader in the field of dermatology drug/device development and medical affairs who will oversee our global clinical development and medical strategy. To learn more:

Welcome back, Jason Shuris

Innovaderm is thrilled to announce the return of Jason Shuris, our new Chief Business Officer. With 25+ years experience in the healthcare and life sciences industries, Jason will oversee the sales and marketing activities at the organization and play a key role in strategy planning and execution. To learn more:

The Step-by-step Challenge

Innovaderm recently organized a unique fundraising challenge in the interest of supporting institutions in Poland who are helping displaced Ukranians to their country. Our goal was to cover 6,500 km (the distance between Montreal and Warsaw!) via walking, running, biking, or even kayaking! For every km traveled between June 3 and July 7, Innovaderm committed […]

Innovaderm Bolsters European Presence With The Addition of Operational Capabilities in Poland and Spain

MONTREAL, QUEBEC, July 28, 2022 – Innovaderm announced today that its strategic European expansion initiative has reached a major milestone with the addition of operational capabilities in Poland and Spain. Biotechnology and pharmaceutical companies can officially partner with the CRO’s team of experts to manage clinical trials in psoriasis, acne, atopic dermatitis and other dermatology […]

Innovaderm Shines as Key Partner in Clinical Development and Study Management of Newly FDA-Approved Psoriasis Drug, Tapinarof

[MONTREAL, QUEBEC – July 21, 2022] Innovaderm’s involvement in all phases of the clinical development of tapinarof culminated with a tremendous achievement: the recent approval of Dermavant Sciences’ VTAMA® (tapinarof) cream by the FDA for the treatment of plaque psoriasis in adults. Discovered in Canada, tapinarof is approved in the United States for the management […]

Innovaderm is Pleased to Announce the Acquisition of Excelsus Statistics

[MONTREAL, QUEBEC – July 5, 2022] Innovaderm, a leading CRO in dermatology, has expanded its biometrics capacity following the acquisition of Excelsus Statistics, a Montreal-based company specialized in biostatistical and SAS programming services with a special expertise in adaptive trial design, as well as activities in many different therapeutic areas. “We are pleased to grow […]

Proud to Support Research Excellence

Innovaderm has generously donated $350,000 to The Montreal Dermatology Research Institute (MDRI) to fund educational initiatives and research into skin-related neglected tropical diseases. We are proud to support the work of a world-class organization dedicated to the development of new treatments and therapeutic interventions that may have a significant impact on the quality of life […]

Innovaderm Honoured With a CRO Leadership Award Again This Year

Win anchors reputation as a CRO of choice by sponsors [MONTREAL, QUEBEC – May 2, 2022] Innovaderm is the proud recipient of a 2022 CRO Leadership Award after garnering outstanding support in the Quality and Reliability categories. This is the second consecutive win for the high-achieving dermatology CRO. “We are very pleased to have been […]

In-Person Breakfast Event at the AAD Boston 2022

Innovaderm will be hosting a free breakfast event on March 26 at the AAD's Annual Meeting in Boston. Skin Barrier Dysfunction: Atopic Dermatitis and Beyond will be presented by dermatology experts Drs. Alan D. Irvine and Robert Bissonnette. For more information, Contact us Newsletter Get notified to have the latest trends and be at the […]

Trial on Chronic Hand Eczema

A warm thank you to our Clinical Research Unit’s sponsor for commending our colleagues’ tremendous efforts in their January newsletter! Innovaderm is proud to collaborate on important clinical studies like their chronic hand eczema trial and help make a difference in the lives of patients with skin disease. Learn more about Innovaderm's clinical studies and […]

Webinar: The Art of Protocol Writing in Dermatology

Join us on January 26th at 11:00 am EDT for an exciting webinar on protocol writing in dermatology with panelists: Dr. Robert Bissonnette (Founder & CEO) Audrey Fortier (Manager, Scientific Affairs) Stéphanie Légaré (Clinical Scientist) Lucile Sinck (Senior Clinical Scientist) Ana Palijan (Scientific Advisor) Come learn about: protocol development and associated tools; protocol considerations for […]

Innovaderm manages a study in PPP and beats recruitment timelines

Aristea recently published Phase 2a clinical data in Dermatology and Therapy from its study managed by Innovaderm Research, highlighting the safety and potential efficacy of Aristea’s lead program RIST4721 for the treatment of moderate to severe palmoplantar pustulosis (PPP). This study came with its challenges from Day 1: It was a study being conducted in […]

Innovaderm will be at the DDDS Conference in Boston!

We are SO excited to be attending our first in-person Summit since 2019! Join us at this year’s Dermatology Drug Development Summit for Inflammatory Skin Diseases, taking place in Boston this November 16-18th. This conference is integral to the industry, and focuses on enhancing next-generation therapies targeting chronic, inflammatory, and autoimmune skin diseases. Innovaderm’s own […]

Clinical research unit design - Platinum Winner - Grand Prix du Design

Platinum Winner - Grand Prix du Design - Health & Research Center We are very proud to announce that L. McComber team has received an award for the stunning design of our state-of-the-art dermatology clinical research unit (CRU). The CRU was specially designed allowing an ideal patient flow and optimal research activities in a very […]

New Scientific Publication on Outcome Measurement Instruments in Atopic Dermatitis

Did you know that we are always acquiring new knowledge to help serve our trial studies better through our multiple internal research programs? We are so excited to share that our very own Dr. Robert Bissonnette, Stephanie Légaré, Ana Palijan and Kevin Kojok, on behalf of @Innovaderm Research Inc, performed a systematic review and meta-analysis […]

Dr. Bissonnette will be speaking on a study sponsored by RAPT

We are thrilled to announce that Dr. Bissonnette will be speaking on a study sponsored by RAPT at the ‘Late-breaking abstract for oral presentation’ session during this year’s 30th Anniversary EADV Congress!   The session will cover the clinical safety and efficacy of RPT193, an oral CCR4 inhibitor, citing results from a randomized, placebo-controlled Phase 1b […]

Innovaderm receives top recognition in the CRO Leadership Awards

MONTREAL — July 6th, 2021 — Innovaderm today announced it has been awarded the CRO Leadership Awards. This huge achievement testifies to the excellency and ever-growing presence in the CRO world. Innovaderm is offering full-service clinical research services, while serving its partners in their journey to discover new dermatology therapies. Being selected by sponsors as top award […]

Innovaderm accredited on rave EDC

We are excited to share that we are officially now a Medidata Service Partner!  The Rave EDC accreditation recognizes leading contract research organizations (CROs), consultancies and systems integrators who are trained on the functionality of the electronic data capture (EDC) and clinical data management (CDM) system, process optimization exercises and scope of Medidata Rave services.  Thank […]

Innovaderm Supports AnaptysBio at the upcoming National Psoriasis Foundation Walk

Innovaderm is thrilled to support AnaptysBio's team at the upcoming NPF walk in San Diego on November 7. Let's raise awareness. Psoriasis is an autoimmune disease that affects 125 million people worldwide. At Innovaderm, we demonstrate our commitment to people living with psoriatic diseases by continuously working to seek medical advancement with our clients. For […]

Collaboration - Dermatology Decentralized Clinical Trials

What do you think about dermatology decentralized clinical trials? Innovaderm is proud to collaborate with Medable in an effort to safely and successfully execute decentralized dermatology trials. Curious to learn more on what we think of the hybrid approach? Please find below the full press release. For more information on our services, visit   […]

Presentation at the upcoming virtual EADV conference

Dr. Robert Bissonnette our president and Founder, will present at the 2020 EADV Virtual conference from Thursday, October 29 to Saturday, October 31. The Innovaderm Research Inc. team contributed to more than 9 sessions, including 5 Late-breaking news, training forum, industry hubs, symposium, and many other sessions. To view the full conference scientific programme and register, please […]

Innovaderm Welcomes its New Vice-President, Biometrics

We are pleased to announce the addition of Pina D'Angelo to Innovaderm’s management team, as Vice-President, Biometrics. This recent hire supports our strategic commitment towards Biometrics, particularly important in the management of our ongoing phase 3 dermatology clinical programs. With her extensive experience as an expert in Biostatistics and Data Management, her participation in numerous meetings with […]

Advancing the Development of Imsidolimab with AnaptysBio

We are excited to share some good news! Congratulations AnaptysBio on the orphan drug designation of imsidolimab for the treatment of GPP! We are thrilled to manage this clinical trial and help advance the development of imsidolimab.   For more information on our services, visit   About Anaptys: AnaptysBio is a clinical-stage antibody development company advancing […]

Innovaderm Moves its Clinical Research Unit Into its new State-of-the-Art Facility

We are thrilled to announce that we recently moved into our new state-of-the-art clinical research unit. As one of the largest dermatology site in North America, we have more than 15 exam rooms, 1 perfusion room, a high volume processing lab and an automated temperature monitoring system (24/7). Thank you L. McComber architecture for working […]